ESR1 and breast carcinoma: An examination of highly expressed circRNA isoforms spliced from ESR1 that were differentially expressed in ER+ breast cancer tissues compared with other malignancies and normal breast tissue were found to be resistant to destruction by ribonuclease R, while the corresponding linear mRNA was prone to degradation by this enzyme.